Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer

Fig. 6

In vivo ROS-related therapy of SG@M. A The schematic illustration of mice tumor therapy (Created with BioRender.com). B Tumor growth curves and C tumor volume changes in six groups during treatment (n = 6). D The relative tumor volume and inhibition rate of tumor growth (IRG) and E the tumor weight at the end of treatment (n = 6). F The bodyweight during treatment (n = 6). G Photos of mice before and after 18 days of treatment and corresponding tumors dissected from mice in six groups after 18 days of treatment. H H&E/TUNEL/Ki-67/HIF-1α/JAK2/p-STAT3 staining of tumor sections after 18 days of treatment in six groups. Scale bar: 50 µm

Back to article page